Low levels of a type of white blood cell called natural killer (NK) cells may help diagnose pulmonary arterial…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
Autotaxin, a protein involved in wound healing and scarring, or fibrosis, was found at higher levels in women with…
Zura Bio has launched a Phase 2 trial to evaluate the safety and efficacy of tibulizumab, its experimental dual…
Fatigue levels in people with scleroderma, also known as systemic sclerosis or SSc, are tied to several social, demographic,…
The specific self-reactive antibodies (autoantibodies) of people with systemic sclerosis (SSc) overlap syndrome — a condition in which SSc…
The Scleroderma Research Foundation (SRF) has announced the star-studded lineup for its annual Cool Comedy, Hot Cuisine fundraising…
Patients with systemic sclerosis (SSc) who have a stem cell transplant see normalized gene activity related to immune function…
CONQUEST, a platform clinical trial launched by the Scleroderma Research Foundation (SRF), is now enrolling people with interstitial lung…
Having scleroderma increases the risk of developing diseases affecting blood vessels of the brain or heart, known as cerebrovascular…
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to BLR-200, a medication that BLR Bio…